Ask AI
ProCE Banner Series

Advancing Outcomes in Lymphoma Care: A Master Class on Integrating the CAR T-Cell Therapies into Clinical Practice

Join us for this interactive, master class, satellite symposium at ASH 2025 featuring discussion, debate, and close collaboration with expert faculty to gain practical strategies in optimizing patient experiences and outcomes with CAR T-cell therapy for various forms of lymphoma. Be sure to bring your questions for the expert panel. 

Friday Satellite Symposium preceding the 67th ASH Annual Meeting and Exposition. 

  AMA
Who Should Attend

This activity aims to improve learners’ knowledge, competence, and performance in application of current and emerging CAR T-cell therapy for patients with various forms of relapsed or refractory B-cell non-Hodgkin lymphoma.

All Events

Advancing Outcomes in Lymphoma Care: A Master Class on Integrating the CAR T-Cell Therapies into Clinical Practice

Upcoming Events

December

05

2025

11:00 AM - 1:30 PM Eastern Time (ET)

In-person

The Hyatt Regency Orlando, 9801 International Dr, Orlando, Florida 32819

11:30 AM - 1:30 PM Eastern Time (ET)

Virtual

Topics

Lymphomas
Hematologic malignancies

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity is intended for hematologists and other healthcare professionals who manage patients with relapsed or refractory B-cell non-Hodgkin lymphoma.

Target Audience
This activity aims to improve learners’ knowledge, competence, and performance in application of current and emerging CAR T-cell therapy for patients with various forms of relapsed or refractory B-cell non-Hodgkin lymphoma.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Demonstrate the ability to select appropriate candidates for CAR T-cell therapy in DLBCL, FL, MCL, and CLL/SLL, applying current evidence and FDA-approved indications

  • Construct comprehensive care plans for patients undergoing CAR T-cell therapy, including referral, pre-treatment preparations, and post-treatment monitoring

  • Formulate evidence-based management strategies for CAR T-cell therapy-related adverse events, including cytokine release syndrome and neurotoxicity

  • Evaluate ongoing clinical trials and emerging data on CAR T-cell therapies for B-cell malignancies to guide appropriate patient enrollment and integrate new findings into clinical practice

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/67167f3d10da3.png

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.com to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191